RADEMACHER JOHN CHARLES 4
4 · Option Care Health, Inc. · Filed May 4, 2026
Research Summary
AI-generated summary of this filing
Option Care Health (OPCH) CEO John Rademacher Buys 12,500 Shares
What Happened
- John Rademacher, CEO of Option Care Health, bought 12,500 shares of OPCH common stock in open-market transactions on May 4, 2026. The weighted average purchase price was $21.18 per share, for a total outlay of approximately $264,706. This was a purchase (insider acquisition), which investors often view as a more informative signal than routine sales.
Key Details
- Transaction date: May 4, 2026 (filed May 4, 2026).
- Price: weighted average $21.18; purchase prices ranged from $21.14 to $21.18 per share (footnote indicates multiple trades).
- Shares acquired: 12,500; total value ≈ $264,706.
- Shares owned after transaction: not disclosed in the provided filing excerpt.
- Footnote: The filing (F1) says the weighted average reflects multiple transactions and the reporting person will provide per-trade details on request to the SEC, issuer, or a security holder.
- Timeliness: Filing date equals the transaction date (no late filing indicated).
- No 10b5-1 plan, option exercise, award, or tax-withholding noted in this filing.
Context
- This was a straightforward open-market purchase (code P). Such purchases represent an insider acquiring company stock rather than selling or exercising derivatives; they are factual signals of personal investment but do not prove motive. Retail investors often track insider buys as one piece of information when evaluating company prospects.
Insider Transaction Report
Form 4
RADEMACHER JOHN CHARLES
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
[F1]2026-05-04$21.18/sh+12,500$264,706→ 695,152 total
Footnotes (1)
- [F1]Reflects the weighted average price of 12,500 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on May 4, 2026 with purchase prices ranging from $21.14 to $21.18 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Signature
/s/ Michael Bavaro, attorney-in-fact for Mr. Rademacher|2026-05-04